RESMED INC

# Signal Note: Deerfield Initiates ResMed Position Deerfield's $2.4M entry into ResMed suggests confidence in the company's digital health and cloud-connected respiratory/sleep diagnostics platform, which has shown resilience in recurring SaaS revenues despite macro headwinds. The position timing aligns with ResMed's push into AI-driven clinical decision support and expanding international markets, though the relatively modest position size indicates this is a measured conviction trade rather than a thematic bet.